Herzschrittmachertherapie + Elektrophysiologie Template
Write in a clean editor, then format for Herzschrittmachertherapie + Elektrophysiologie in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Herzschrittmachertherapie + Elektrophysiologie format
Herzschrittmachertherapie + Elektrophysiologie is a peer-reviewed journal published by Springer Nature, covering Cardiac Arrhythmias and Treatments, Cardiac pacing and defibrillation studies, Cardiac electrophysiology and arrhythmias.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Herzschrittmachertherapie + Elektrophysiologie 12, 45–58 (2023).
Formats any DOI in Herzschrittmachertherapie + Elektrophysiologie style. No sign-up. |
| Publishes research in | Cardiac Arrhythmias and Treatments Cardiac pacing and defibrillation studies Cardiac electrophysiology and arrhythmias Atrial Fibrillation Management and Outcomes Cardiovascular Syncope and Autonomic Disorders |
| ISSN | 0938-7412 |
| Citation impact (2-yr) | 1.09 |
| h-index | 24 |
| i10-index | 122 |
| Total citations | 5,797 |
| Article processing charge | $3,090 |
| Top institutions publishing here | Evangelisches Krankenhaus Bielefeld |
| Journal website | link.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Herzschrittmachertherapie + Elektrophysiologie per year
Citation impact of Herzschrittmachertherapie + Elektrophysiologie by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Herzschrittmachertherapie + Elektrophysiologie
BACKGROUND AND OBJECTIVES: Catheter ablation of atrial fibrillation (AF) has become a well-established and widely used therapy, with pulmonary vein isolation (PVI) being the key modality of ablation. However, arrhythmia recurrences after PVI are common, with a relevant number of patients undergoing repeat ablation. Arrhythmia recurrence after PVI may vary regarding time point and mode…
Cardiac implantable electronic devices have been successfully treating patients with brady- and tachyarrhythmias for decades. However, there are still significant complications related to this therapy modality, many related to the transvenous lead. Paradigm-shifting technologies, such as the subcutaneous implantable cardioverter-defibrillator (S-ICD) and leadless cardiac pacemakers (LCP), have emerged to address these complications. The novel modular…